Ignite Creation Date:
2024-05-05 @ 4:45 PM
Last Modification Date:
2024-10-26 @ 9:23 AM
Study NCT ID:
NCT00300118
Status:
COMPLETED
Last Update Posted:
2014-05-19
First Post:
2006-03-07
Brief Title:
Oral Budesonide vs Oral Mesalazine in Active Crohns Disease CD
Sponsor:
Dr Falk Pharma GmbH
Organization:
Dr Falk Pharma GmbH
Organization Data
Organization:
Dr Falk Pharma GmbH
Class:
INDUSTRY
Study ID:
BUC-52CDA
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Dr Falk Pharma GmbH
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None